GPCR anterograde trafficking
GPCR 顺行贩运
基本信息
- 批准号:10592294
- 负责人:
- 金额:$ 35.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdrenergic ReceptorAreaBinding ProteinsBiochemicalCell membraneCell physiologyCell surfaceDestinationsDiseaseDrug DesignDrug TargetingEarEndoplasmic ReticulumG-Protein-Coupled ReceptorsGoalsGolgi ApparatusHormonesImaging TechniquesMembrane ProteinsModelingMolecularPathologicPathway interactionsPharmaceutical PreparationsPharmacotherapyPhysiologicalPost-Translational Protein ProcessingProteinsRegulationResearchRodRoleRouteSortingUbiquitinationalpha helixgenetic regulatory proteininsightlive cell imagingnovelprogramsprotein functionprototypereceptorresponsestructural determinantstargeted treatmenttrafficking
项目摘要
Summary
G protein-coupled receptors (GOCRs) regulate a variety of cell functions and are important targets of
therapeutics. A fundamental but poorly understood question in studying GPCRs is how targeted GPCR
trafficking is achieved. The overall goal of our research program is to elucidate the molecular mechanisms
of nascent GPCR targeting to their functional destinations and to understand the role of targeting in
modulating cellular responses to hormones and drugs. Under this broad objective, this proposal will use α2-
adrenergic receptors (α2-ARs) as models to address the following two questions which are central to
understanding GPCR anterograde trafficking: 1) how newly synthesized GPCRs export from the
endoplasmic reticulum (ER) and then transport en route from the ER through the Golgi to the cell surface;
and 2) how GPCRs are sorted from one another and from non-GPCR plasma membrane proteins during
their traffic along the biosynthetic pathway. The premise of this project is our recent findings that the ER-
Golgi-cell surface transport and sorting of α2A-AR and α2B-AR, two closely related, prototypic GPCRs, are
coordinated by ufmylation, an ubiquitination-like post-translational modification, and three interacting
proteins, C1orf27 (an ER membrane protein), coiled-coil α-helical rod protein 1 (HCR1) and Golgi-localized γ
ear-containing ARF-binding protein 3 (GGA3). We will define the novel functions of protein ufmylation and
C1orf27 in the ER-Golgi transport and sorting, as well as HCR1 and GGA3 in the post-Golgi traffic and
sorting of α2A-AR and α2B-AR, and elucidate the underlying mechanisms. The proposed research is a
continuation of our long-standing efforts to study the anterograde trafficking of GPCRs, which have led to
the discovery of a number of structural determinants and regulatory proteins essential for GPCR export and
sorting. As in the past, we will employ state-of-the-art biochemical, immunochemical and live cell imaging
techniques to dissect the mechanistic aspects of GPCR trafficking along the biosynthetic pathway, including
maturation, sorting and targeting. These studies will provide important insights into regulation of GPCR
export trafficking which is a poorly explored area in the study of the GPCR superfamily.
概括
G蛋白偶联受体(GOCR)调节多种细胞功能,是
治疗。在研究GPCR中的基本但不理解的问题是目标GPCR如何
实现了贩运。我们研究计划的总体目标是阐明分子机制
新生的GPCR靶向其功能目的地,并了解靶向的作用
调节对激素和药物的细胞反应。在这个广泛的目标下,该建议将使用α2-
肾上腺素受体(α2-ar)作为模型,以解决以下两个问题,这些问题是
了解GPCR顺行贩运:1)新合成GPCR的出口如何
内质网(ER),然后从ER穿过高尔基体到细胞表面运输;
2)如何将GPCR彼此分类,并在非GPCR质膜蛋白中分类
它们沿着生物合成途径的交通。该项目的前提是我们最近的发现,
α2A-AR和α2B-AR的Golgi细胞表面转运和两个密切相关的原型GPCR是
由ufmylation协调,泛素化后翻译后修饰和三个相互作用
蛋白质,C1ORF27(ER膜蛋白),盘绕螺旋α-螺旋杆蛋白1(HCR1)和高尔基体钙化γ
含耳朵的ARF结合蛋白3(GGA3)。我们将定义蛋白质ufmylation的新功能和
er-golgi运输和分类中的C1orf27,以及后高尔基人的HCR1和GGA3,
α2A-AR和α2B-AR的排序,并阐明了基本机制。拟议的研究是
继续我们长期以研究GPCR的顺行贩运的努力,这导致了GPCR
发现许多对于GPCR出口所必需的结构决定者和调节蛋白的发现
排序。与过去一样,我们将采用最先进的生化,免疫化学和活细胞成像
剖析沿生物合成途径的GPCR贩运机械方面的技术,包括
成熟,分类和定位。这些研究将为调节GPCR提供重要的见解
出口贩运是在GPCR超家族研究中探索的一个探索区域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUANGYU WU其他文献
GUANGYU WU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUANGYU WU', 18)}}的其他基金
ER-to-Golgi traffic and signal regulation of GPCRs
GPCR 的 ER 至高尔基体交通和信号调节
- 批准号:
7924966 - 财政年份:2009
- 资助金额:
$ 35.42万 - 项目类别:
ER-to-Golgi traffic and signal regulation of GPCRs
GPCR 的 ER 至高尔基体交通和信号调节
- 批准号:
7227755 - 财政年份:2006
- 资助金额:
$ 35.42万 - 项目类别:
COBRE: LSU HSC: P4: ER TO GOLGI T & VSMC
COBRE:LSU HSC:P4:ER 至高尔基 T
- 批准号:
7382066 - 财政年份:2006
- 资助金额:
$ 35.42万 - 项目类别:
ER-to-cell surface transport and signal regulation of GPCRs
GPCR 的 ER 至细胞表面转运和信号调节
- 批准号:
7887450 - 财政年份:2006
- 资助金额:
$ 35.42万 - 项目类别:
ER-to-Golgi traffic and signal regulation of GPCRs
GPCR 的 ER 至高尔基体交通和信号调节
- 批准号:
7615540 - 财政年份:2006
- 资助金额:
$ 35.42万 - 项目类别:
ER-to-Golgi traffic and signal regulation of GPCRs
GPCR 的 ER 至高尔基体交通和信号调节
- 批准号:
7015202 - 财政年份:2006
- 资助金额:
$ 35.42万 - 项目类别:
ER-to-cell surface transport and signal regulation of GPCRs
GPCR 的 ER 至细胞表面转运和信号调节
- 批准号:
8067914 - 财政年份:2006
- 资助金额:
$ 35.42万 - 项目类别:
相似国自然基金
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
- 批准号:82370408
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
心脏成纤维细胞β2-肾上腺素能受体对心衰小细胞外囊泡释放的作用机制研究
- 批准号:82370276
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
α1-和β3-肾上腺素能受体的荧光探针可视化研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
β2肾上腺素能受体调控皮肤角化细胞活化在慢性重叠型疼痛状态中的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
The role of the endothelial NPYR1-TRPC3-ET1 signaling axis in neurovascular coupling dysfunction
内皮NPYR1-TRPC3-ET1信号轴在神经血管耦合功能障碍中的作用
- 批准号:
10667097 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
ANG1-7 as an intervention for Alzheimer's Disease.
ANG1-7 作为阿尔茨海默病的干预措施。
- 批准号:
10592577 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
CRISPR-mediated engineering and pilot study of mouse mutants of the bitter taste receptor genes
CRISPR介导的小鼠苦味受体基因突变体工程和初步研究
- 批准号:
10451169 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别:
Risk-Based Primary Prevention of Heart Failure
基于风险的心力衰竭一级预防
- 批准号:
10516468 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别:
Risk-Based Primary Prevention of Heart Failure
基于风险的心力衰竭一级预防
- 批准号:
10689211 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别: